Literature DB >> 28770621

Longitudinal Perioperative Pain Assessment in Head and Neck Cancer Surgery.

Marisa R Buchakjian1,2, Andrew B Davis1, Sebastian J Sciegienka3, Nitin A Pagedar1, Steven M Sperry1.   

Abstract

OBJECTIVE: To evaluate perioperative pain in patients undergoing major head and neck cancer surgery and identify associations between preoperative and postoperative pain characteristics.
METHODS: Patients undergoing head and neck surgery with regional/free tissue transfer were enrolled. Preoperative pain and validated screens for symptoms (neuropathic pain, anxiety, depression, fibromyalgia) were assessed. Postoperatively, patients completed a pain diary for 4 weeks.
RESULTS: Twenty-seven patients were enrolled. Seventy-eight percent had pain prior to surgery, and for 38%, the pain had neuropathic characteristics. Thirteen patients (48%) completed at least 2 weeks of the postoperative pain diary. Patients with moderate/severe preoperative pain report significantly greater pain scores postoperatively, though daily pain decreased at a similar linear rate for all patients. Patients with more severe preoperative pain consumed greater amounts of opioids postoperatively, and this correlated with daily postoperative pain scores. Patients who screened positive for neuropathic pain also reported worse postoperative pain.
CONCLUSION: Longitudinal perioperative pain assessment in head and neck patients undergoing surgery suggests that patients with worse preoperative pain continue to endorse worse pain postoperatively and require more narcotics. Patients with preoperative neuropathic pain also report poor pain control postoperatively, suggesting an opportunity to identify these patients and intervene with empiric neuropathic pain treatment.

Entities:  

Keywords:  head and neck cancer; neuropathic pain; perioperative pain; reconstructive surgery

Mesh:

Substances:

Year:  2017        PMID: 28770621     DOI: 10.1177/0003489417723034

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Short- and Long-term Opioid Use in Patients with Oral and Oropharynx Cancer.

Authors:  Jessica D McDermott; Megan Eguchi; William A Stokes; Arya Amini; Mohammad Hararah; Ding Ding; Allison Valentine; Cathy J Bradley; Sana D Karam
Journal:  Otolaryngol Head Neck Surg       Date:  2018-11-06       Impact factor: 3.497

2.  Dysphagia, voice problems, and pain in head and neck cancer patients.

Authors:  Andreas Hinz; Susanne Wiegand; Veit Zebralla; Gunnar Wichmann; Markus Pirlich; Carola Hammermüller; Thomas Berger; Klara Zimmermann; Thomas Neumuth; Anja Mehnert-Theuerkauf; Andreas Dietz
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-16       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.